skip to content
   

Acute Limb Ischemia
A Market of Multiple Therapies and Multiple Procedures

Analyzes the disease, causes, morbidity and mortality. Treatments explored include surgery, thromboembolectomy, thrombolysis, percutaneous mechanical thrombectomy (PMT), excimer laser, ultrasonic thrombectomy and ultrasound-mediated microbubble destruction. Currently approved, as well as investigational drugs and devices are analyzed.

Detailed estimates of the number of patients presenting with acute limb ischemia are provided, as well as projected for 2000 through 2020.

The ALI market is analyzed by number of primary and revision procedures, by cause and by clinical classification. Market estimates are projected for each of these for the years 2000 through 2020. The 2000-2020 market potential for thrombolytics, PMT devices, new endovascular devices, GP IIb/IIIa inhibitors and thromboembolectomy is analyzed and projected.

Price: $4,100

To purchase call us at 404 816-0746 or
contact witherspoon@thesagegroup.us

Table of Contents

Index of Tables and Figures

References-First and Last Pages

List of Companies

Sample Pages [Available on Request]

 

Powered by Website Baker, design by Atlanta Based MaxxWebs Design and Development